Important clinical studies that changed the clinical practice of advanced breast cancer in 2024
With advancements in molecular biology research and precision medicine, treatment options for advanced breast cancer have become increasingly diverse. In 2024, significant research progress has been achieved across different molecular subtypes of advanced breast cancer. Endocrine therapy combined wi...
Saved in:
| Main Author: | WU Song, YUAN Yang, JIANG Zefei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2025-02-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1742381061929-448811518.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision diagnosis and treatment of breast cancer in the post-CDK4/6 inhibitor era
by: LI Bin, TAO Zhonghua, HU Xichun
Published: (2025-03-01) -
Ribociclib-induced vitiligo in a case of metastatic carcinoma of the breast
by: Abhira Deb, et al.
Published: (2025-01-01) -
Gut microbiota interact with breast cancer therapeutics to modulate efficacy
by: Alana A Arnone, et al.
Published: (2025-01-01) -
Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 − advanced breast cancer: a meta-analysis
by: Isah Adamu Danbala, et al.
Published: (2025-06-01) -
Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Radiotherapy in Curative Breast Cancer Patients Induced Pneumonitis: A Case Report
by: Pei-Yu Hou
Published: (2025-04-01)